Evidence map›Paper›PMID 30421076›Full record

ArticleSurgical endoscopy2019

Robotic-assisted versus laparoscopic left pancreatectomy at a high-volume, minimally invasive center.

William B Lyman, Michael Passeri, Amit Sastry, Allyson Cochran, David A Iannitti, Dionisios Vrochides, Erin H Baker, John B Martinie

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. RoboticFrontiers in oncology · 2021
    Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. [Robotic pancreatic surgery].Chirurgie (Heidelberg, Germany) · 2024
    Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

William B LymanDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA. william.lyman@carolinashealthcare.org.
Michael PasseriDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
Amit SastryDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
Allyson CochranDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
David A IannittiDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
Dionisios VrochidesDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
Erin H BakerDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
John B MartinieDivision of HPB Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWhile minimally invasive left pancreatectomy has become more widespread and generally accepted over the last decade, opinions on modality of minimally invasive approach (robotic or laparoscopic) remain mixed with few institutions performing a significant portion of both operative approaches simultaneously.

methods247 minimally invasive left pancreatectomies were retrospectively identified in a prospectively maintained institutional REDCap™ database, 135 laparoscopic left pancreatectomy (LLP) and 108 robotic-assisted left pancreatectomy (RLP). Demographics, intraoperative variables, postoperative outcomes, and OR costs were compared between LLP and RLP with an additional subgroup analysis for procedures performed specifically for pancreatic adenocarcinoma (35 LLP and 23 RLP) focusing on pathologic outcomes and 2-year actuarial survival.

resultsThere were no significant differences in preoperative demographics or indications between LLP and RLP with 34% performed for chronic pancreatitis and 23% performed for pancreatic adenocarcinoma. While laparoscopic cases were faster (p < 0.001) robotic cases had a higher rate of splenic preservation (p < 0.001). Median length of stay was 5 days for RLP and LLP, and rate of clinically significant grade B/C pancreatic fistula was approximately 20% for both groups. Conversion rates to laparotomy were 4.3% and 1.8% for LLP and RLP approaches respectively. RLP had a higher rate of readmission (p = 0.035). Pathologic outcomes and 2-year actuarial survival were similar between LLP and RLP. LLP on average saved $206.67 in OR costs over RLP.

conclusionsThis study demonstrates that at a high-volume center with significant minimally invasive experience, both LLP and RLP can be equally effective when used at the discretion of the operating surgeon. We view the laparoscopic and robotic platforms as tools for the modern surgeon, and at our institution, given the technical success of both operative approaches, we will continue to encourage our surgeons to approach a difficult operation with their tool of choice.

Indexed as

Cytoreduction Surgical ProceduresLaparoscopyPancreatectomyPancreatic NeoplasmsRobotic Surgical ProceduresFemaleHospitals, High-VolumeHumansLength of StayMaleMiddle AgedOutcome and Process Assessment, Health CarePancreatitis, ChronicRetrospective StudiesDistal pancreatectomyLaparoscopic pancreatectomyLeft pancreatectomyMinimally invasive pancreatectomyRobotic-assisted pancreatectomyRobotic pancreatectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.